Trial Profile
A Multi-Center, Open Label Study To Evaluate Long Term Safety Of Caduet In Patient With Both Of Hypertension And Hypercholesterolemia, Or With Both Of Angina Pectoris And Hypercholesterolemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Angina pectoris; Hypercholesterolaemia; Hypertension
- Focus Adverse reactions
- Sponsors Pfizer
- 22 Feb 2012 Actual patient number is 159 according to ClinicalTrials.gov.
- 22 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.